Transplant dose of CD34+ and CD3+ cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back-Reference-Cited by-同舟云学术

Transplant dose of CD34+ and CD3+ cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back

Published:2001-10 Issue:1 Volume:115 Page:95-104
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Nakamura Ryotaro,Bahceci Erkut,Read Elizabeth J.,Leitman Susan F.,Carter Charles S.,Childs Richard,Dunbar Cynthia E.,Gress Ronald,Altemus Rosemary,Young Neal S.,Barrett A. John

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.02983.x/fullpdf

Reference38 articles.

1. Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors;Agarwal;Blood,1995

2. Bone marrow transplantation for chronic myeloid leukemia: T cell depletion with Campath-1 reduces the incidence of acute graft-versus-host disease but may increase the risk of leukemia relapse;Apperley;Bone Marrow Transplantation,1986

3. Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood stem cells in adults with advanced leukemia;Bacigalupo;Blood,1996

4. Allogeneic bone marrow or peripheral blood cell transplant in adults with hematopoietic malignancies: a single-center experience;Bacigalupo;Experimental Hematology,1998

5. CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies;Bahceci;British Journal of Haematology,2000

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Graft CD3⁺ T-Cell Dose on the Outcome of T-Cell Replete Human Leukocyte Antigen-Mismatched Allogeneic Hematopoietic Peripheral Blood Stem Cells Transplantation;Journal of Hematology;2023-02

2. An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes;Cytotherapy;2022-04

3. Variable impact of graft CD3+ cell content on graft versus host disease in hematopoietic stem cell transplant recipients: Is the role of donor CD3+ cells overestimated?;Transfusion and Apheresis Science;2021-12

4. Peripheral blood stem cell grafts in allogeneic hematopoietic cell transplantation: It is not all about the CD34+ cell dose;Transfusion and Apheresis Science;2021-02

5. Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2019-09